The leading biopharmaceutical stock refers to an enterprise with core biopharmaceutical technology and market competitiveness. With the growth of medical and health needs and the progress of science and technology, biopharmaceutical industry has great development potential. What is the biomedical medical leading stock brought by the following small series? This will do you a lot of good. Let's have a look.
What is the leading stock of biomedicine and medical treatment?
Biomedical leading stocks include the following:
1, Zhongheng Group 600252
2. Zhejiang Longsheng 600352
3. Oriental Sunshine 600673
4. Yuheng Pharmaceutical 002437
5. china baoan 000009
6. tonghua dongbao 600867
7. Shanghai Medical Insurance 60 1607
8. Fosun Pharma 600 196
9. Winbond Health 002004
10, Jiangsu Sunshine 600220
What are the leading stocks in the biomedical sector?
Biomedical plate is one of the hot industries in the current capital market, and many listed companies have strong competitiveness and performance.
Leading stocks mainly include: United Amino Acid, Hengrui Pharma, Yao Ming Bio, Mindray Medical, etc. These companies have high technical content and innovative ability in the fields of biopharmaceuticals, medical diagnosis and health services, and have broad market prospects. Investors can pay attention to these enterprises with leading potential and invest cautiously according to the actual situation.
What are the leading stocks of pharmaceutical listed companies?
The leading shares of listed pharmaceutical companies are Tencent Holdings Limited, Yao Ming Bio and China Bio-Pharmaceutical.
1. Tencent Holdings Limited (00700. HK): Tencent Medical Health, a pharmaceutical subsidiary of Tencent, is one of the leading Internet medical platforms in China and one of the leading enterprises in the pharmaceutical industry.
2. Yao Ming Biology (02269. HK): A biopharmaceutical company specializing in innovative drug research and development, and one of the largest drug research and development outsourcing service providers in China.
3. Yao Ming Biology (02269. HK): A biopharmaceutical company specializing in innovative drug research and development, and one of the largest drug research and development outsourcing service providers in China.
Doctor's leading stock list
The leading stocks of medical biology are: Hengrui Pharma (600276), Fosun Pharma (600 196), Yunnan Baiyao (000538), Xinlitai (00282 1) and Aier Ophthalmology (3000 15).
Chemical pharmacy
It is the pioneer and leader of innovative drug research and development in China. The company is a leading company in the field of innovative drugs in China, with a complete product structure and R&D channels. Leading the research and development of innovative drugs. Pirotinib is independently developed by the company 1. An innovative drug is the company's blockbuster product. The indication market of pirotinib for breast cancer is $65.438+$400 million, and its indication will be extended to lung cancer and gastric cancer in the future.
Fosun Pharma
600 196
Shanghai stock market
Biopharmaceutical Ⅱ
Fu Honghanlin is a biopharmaceutical R&D and production platform with 6 1.093 shares. The research and development strength and progress of biosimilars are in a leading position in China. It is expected that biosimilars such as rituximab, trastuzumab and adalimumab will be approved in the next three years. The biosimilars market is large, with many heavyweight products, high entry threshold and low medical insurance support. In the long run, they are optimistic about the oligopoly competition model.
Yunnan Baiyao
000538
Shen Shi
Traditional Chinese medicine Ⅱ
This company is one of the famous manufacturers of Chinese patent medicines in China. It is one of the top 50 Chinese patent medicine enterprises. The company's main products are Yunnan Baiyao and natural plant medicine, with dosage form 19, more than 300 varieties, and the sales volume ranks first in Yunnan Province. At present, the company also has Yunnan Baiyao powder and Yunnan Baiyao capsule, which are national first-class protected Chinese patent medicines. On August 20 17 18, Yunnan Baiyao was selected into the health brand list and brand value list of China on August 20 17.
Xinlitai
002294
Small and medium plate
Chemical pharmacy
The internal and external expansion of Shenzhen Lee Tae Pharmaceutical Co., Ltd. is the dual strength of the medical equipment echelon. The company focuses on the development of cardiovascular special drugs, innovative drugs and unique products. Existing patented drugs have unique advantages, forming a pyramid product structure from high-end radiation to downward radiation. The innovative drugs are progressing smoothly, and the clinical use of compound gliptin is in progress. A new anti-heart failure drug S glucagon-like peptide-1-Fc injection fusion protein has been accepted.
The most potential biomedical leading stock
The potential biomedical leading stocks are as follows:
1. Hengrui Pharma, the first innovative drug in China (600276). The main product lines are anti-tumor, anesthesia, contrast agent and so on. The company's return on net assets has remained above 23% for many years, and its net profit has maintained a growth rate of above 20% for many years. The company has strong R&D strength, excellent management team and strong sales ability.
2. Aier Ophthalmology (3000 15), the first unit of domestic ophthalmology chain hospitals. Mainly to provide patients with various ophthalmic diseases diagnosis and treatment, medical optometry and other ophthalmic medical services. The company's return on net assets has remained around 20% for many years, and its net profit has maintained a growth rate of more than 30% for many years.
3. The first domestic medical device, Mindray Medical (300760). The main product lines are life and information support, in vitro diagnosis, medical imaging and so on. The company's return on net assets has remained above 25% for many years, and its net profit has maintained a growth rate of above 25% for many years.
What stocks are there in the biomedical sector of listed companies?
Tiantan Bio, Guangshengtang, Dongbao Bio, Zhenghai Bio, Lexin Medical, etc.
1, Tiantan creature
The full name of the company is Beijing Tiantan Biological Products Co., Ltd. ("Tiantan Biological" for short), and the listed stock is Tiantan Biological (600 16 1). Is an enterprise engaged in the research, production and management of biological products such as vaccines, blood preparations and diagnostic supplies. , initiated by Beijing Institute of Biological Products and listed on the Shanghai Stock Exchange on 1998, is now controlled by China Biotechnology Group Company.
2. Guangshengtang
The full name of the company is Fujian Guangshengtang Pharmaceutical Co., Ltd., and the listed stock is Guangshengtang (300436). It is a modern pharmaceutical enterprise integrating drug research and development, production and sales, and a modern GMP certification factory.
3. Dongbao Bio
The full name of the company is Baotou Dongbao Biotechnology Co., Ltd., established in 1997, and the listed stock is Dongbao Bio (300239), which is a professional manufacturer of gelatin and collagen extension products. National high-tech enterprise, one of the top 50 private enterprises in Inner Mongolia, 20 1 1 was successfully listed in Shenzhen A-share. Mainly engaged in gelatin series products, collagen and calcium hydrogen phosphate.